PON3 anticorps (AA 250-350)
Aperçu rapide pour PON3 anticorps (AA 250-350) (ABIN7269174)
Antigène
Voir toutes PON3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 250-350
-
Fonction
- PON3 Rabbit pAb
-
Séquence
- HDNWDLTQLK VIQLGTLVDN LTVDPATGDI LAGCHPNPMK LLNYNPEDPP GSEVLRIQNV LSEKPRVSTV YANNGSVLQG TSVASVYHGK ILIGTVFHKT L
-
Réactivité croisée
- Humain
-
Attributs du produit
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogène
- A synthetic peptide corresponding to a sequence within amino acids 250-350 of human PON3 (NP_000931.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB,1:500 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- PON3 (Paraoxonase 3 (PON3))
-
Autre désignation
- PON3
-
Sujet
- This gene is a member of the paraoxonase family and lies in a cluster on chromosome 7 with the other two family members. The encoded protein is secreted into the bloodstream and associates with high-density lipoprotein (HDL). The protein also rapidly hydrolyzes lactones and can inhibit the oxidation of low-density lipoprotein (LDL), a function that is believed to slow the initiation and progression of atherosclerosis. Alternatively spliced variants which encode different protein isoforms have been described, however, only one has been fully characterized.,PON3,Cancer,Signal Transduction,Endocrine & Metabolism,Drug metabolism,Neuroscience,Neurodegenerative Diseases,Dopamine Signaling in Parkinson's Disease,Cardiovascular,Lipids,Lipoproteins/Apolipoproteins,PON3
-
Poids moléculaire
- 39kDa
-
ID gène
- 5446
-
UniProt
- Q15166
-
Pathways
- Monocarboxylic Acid Catabolic Process
Antigène
-